Track topics on Twitter Track topics that are important to you
Finn-Medi Research was established in 1995 and it is owned by Finnvera, the Hospital District of Pirkanmaa, the Finnish National Fund for Research and Development (SITRA), Finnish Red Cross, City of Tampere, Tampere University of Technology Foundation, and Tampere University Foundation. The company has 14 permanent employees and its projects involve more than 100 people annually. Finn-Medi Research implements some 100 projects per year. Our Turnover in 2004 was 2,4 M€. With its skilled staff and through its wide national and international connections to research institutions, financiers, corporations and other development companies, FinnMedi can offer a covering network and appropriate expertise to its customers' service
Biokatu 12, 4 th floor
Phone: 358 3 3116 4023
Fax: 358 3 3116 4029
VANCOUVER, BRITISH COLUMBIA - September 1, 2017 (Investorideas.com Newswire) Standard Graphite Corp. (TSX VENTURE:SGH) (the "Company") is pleased to announce that it has entered into a share purchase ...
(PRWEB) September 20, 2017 âFinn Mousesonâ: follows the exciting story of a mouse as the need for adventure decides to tak...
Scary flicks made Finn Wolfhard famous -- but comedy may be his true calling.
In this episode of PharmaTelevision News Review, Fintan Walton talks to Dr Finn Benned Hansen, Corporate VP Strategy and Sourcing, Novo Nordisk.
Smithsburg, Maryland (PRWEB) September 07, 2017 MEDI+SIGN announces the recent designation of ResponderSync Partner by Rauland-Borg,...
California officials are being asked to review the requirement that massive, printed books be sent out to people who enroll for Medi-Cal. Outlets report on other Medicaid news out of South Carolina an...
Medi-Dose/EPS, makers of solutions for preventing medication errors, have recently published a white paper, “Bar Codes and Bar Code Scanners for Unit Dose Medication In a Healthcare Setting.&rdq...
MEDI+SIGN partners with Rauland-Borg to expand connectivity portfolio and to create the ideal communications solution for Rauland ResponderSync users Smithsburg, Maryland (PRWEB) September 07, 2017 M...
Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Berry
Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Mint
Denti-Care Denti-Freeze Topical Anesthetic Gel Strawberry
Denti-Care Denti-Freeze Topical Anesthetic Gel Raspberry
Mental disorders (MeDi) and suicide attempts (SA) are influenced by environmental and genetic factors. Genetic polymorphism studies have identified some candidate genes for suicidal behaviour in peopl...
MEDI-570 is a fully human afucosylated monoclonal antibody (MAb) against Inducible T-cell costimulator (ICOS), highly expressed on CD4+ T follicular helper (TFH) cells. Effects of MEDI-570 were evalua...
Evidence from epidemiologic studies suggests a relation between the Mediterranean diet (MeDi) and cognitive function, but results are inconsistent. Prior reviews have not provided pooled data from met...
Little is known about the importance of the Mediterranean Diet (MeDi) and dietary intake as environmental neuroprotective factors in Huntington's disease (HD); so, we evaluated and analyzed the preval...
The Mediterranean dietary pattern has been associated with a decreased risk of many degenerative diseases and cognitive function in particular; however, relevant information from Mediterranean regions...
The purpose of this study is to evaluate the safety and tolerability of MEDI-570 in adult subjects with moderately to severely active systemic lupus erythematosus (SLE).
The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-545 compared with placebo, over a dose escalation range of 0.3-30 mg/kg, i...
To assess the safety of escalating dose levels of MEDI-507 in pediatric stem cell and bone marrow allograft recipients who have at least Grade II GvHD.
To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.
A Phase I studyto evaluate the safety and tolerability of escalating subcutaneous (SC) doses of MEDI-528 in to healthy adult volunteers.
Finn-Medi Research was established in 1995 and it is owned by Finnvera, the Hospital District of Pirkanmaa, the Finnish National Fund for Research and Development (SITRA), Finnish Red Cross, City of T...
Histola Ltd is established to provide a comprehensive range of histological techniques to meet each investigators needs. Our team is offering decades of combined experience in all phases of histopatho...
Medi-Span is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer author...
We have published hundreds of Finn-Medi Research news stories on BioPortfolio along with dozens of Finn-Medi Research Clinical Trials and PubMed Articles about Finn-Medi Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Finn-Medi Research Companies in our database. You can also find out about relevant Finn-Medi Research Drugs and Medications on this site too.